Intercept to Present at Upcoming Conference

NEW YORK, March 30, 2017 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced management will be participating in the following investor conference:

• 16th Annual Needham Healthcare Conference on April 4, 2017 at 11:20 a.m. Eastern Time

Webcast information for this event will be available on the Investors page of Intercept's website at http://ir.interceptpharma.com. Archived webcasts will be available on Intercept's website for approximately two weeks.

About InterceptIntercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. Founded in 2002 in New York, Intercept now has operations in the United States, Europe and Canada.

CONTACT:
For more information about Intercept Pharmaceuticals, please contact:

Intercept Pharmaceuticals:
Mark Vignola
+1-646-747-1000
[email protected]

Media inquiries: [email protected]

Investor inquiries: [email protected]

Source: Intercept Pharmaceuticals, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cardano Price Prediction: ADA Near $0.224 and a Busy Transaction Epoch Meet Remittix’s November Launch Story
• IntelliXR Launches Its Platform for Eye and Brain Biomarkers
• Valley Community Healthcare to Host Two Voter Events in October